Business
Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today
About this update from Quantum-si Incorporated
[{"type":"text","content":" BRANFORD, Conn.--(BUSINESS WIRE)--\nQuantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Canaccord Genuity 44th Annual Growth Conference taking place in Boston August 13-15, 2024.\n\n\nJeff Hawkins, Quantum-Si's Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will participate in a fireside chat on Tuesday, August 13th, at 11:00 AM ET.\n\n\nA live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.\n\n\nAbout Quantum-Si Incorporated\n\n\nQuantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240730798589/en/\n\nInvestor Contact\nDoug Farrell, VP, Investor Relations\[email protected]\n\nMedia Contact\nKatherine Atkinson, SVP of Commercial Marketing\[email protected]\n\n\nSource: Quantum-Si Incorporated","length":3884,"tagName":"div"}]